| Patents for C07D - Heterocyclic compounds (10,420) |
|---|
| 05/18/2006 | WO2005051301A3 Heterocyclic inhibitors of mek and methods of use thereof |
| 05/18/2006 | WO2005007623A3 Inhibition of syk kinase expression |
| 05/18/2006 | CA2585310A1 5-heteroaryl thiazoles and their use as p13k inhibitors |
| 05/17/2006 | EP1656382A2 4-biphenylsubstituted pyrazolidin-3,5-dione derivatives |
| 05/17/2006 | EP1656346A1 Novel substituted 3-sulfur indoles |
| 05/17/2006 | EP1656183A1 Treatment of male sexual dysfunction |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1109787B1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 05/17/2006 | CN1772733A Cyanopyrrolidine derivatives |
| 05/17/2006 | CN1256328C Position seven substituted amine methyl fluoro quinolone derivative having antibacterial activity and its preparation method |
| 05/17/2006 | CN1256085C Sertraline salts and substained-release dosage forms of sertraline |
| 05/11/2006 | US20060100167 Methods and compositions for the treatment of autoimmune disorders using clofarabine |
| 05/11/2006 | US20060099323 Comprises successive steps of controlled dehydration of fresh avocados or of avocados that have undergone preliminary transformations, extraction of oil from dehydrated fruit, heat treatment of oil, concentration of unsaponifiable fraction |
| 05/10/2006 | EP1654256A2 Tetrahydropyran heterocyclic cyclopentyl heteroaryl modulators of chemokine receptor activity |
| 05/10/2006 | EP1654231A2 Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders |
| 05/10/2006 | EP1654217A1 2- adamantyl derivatives as p2x7 receptor antagonists. |
| 05/10/2006 | EP1653968A2 Method for modulating calcium ion-release-activated calcium ion channels |
| 05/10/2006 | EP1653960A2 Melanin concentrating hormone receptor antagonist |
| 05/10/2006 | EP1653949A2 Pyrazole carboxamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 05/10/2006 | EP1653946A2 Geometrically restricted 3-cyclopentylidene-1,3-dihydroindol-2-ones as potent protein kinase inhibitors |
| 05/10/2006 | EP1497290A4 Process for preparing acid salts of gemifloxacin |
| 05/10/2006 | EP1104403B1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 05/10/2006 | CN1771234A Process for preparing pyrrolotriazine kinase inhibitors |
| 05/10/2006 | CN1770980A Pyrazoles and methods of making and using the same |
| 05/10/2006 | CN1255404C Process for preparing substituted imidazopyridine compound |
| 05/10/2006 | CN1255377C Intermediate for preparing isoxazolinyl-3-acylbenzene and process for preparing said intermediate |
| 05/09/2006 | US7041679 Crystallization, filtration; neurokinins receptor antagonist |
| 05/04/2006 | US20060094740 Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 05/04/2006 | US20060094724 inhibitor of activated blood coagulation factor X; N-(5-chloropyridin-2-yl)-3- {[(trans-4-pyrrolidin-1 -ylcyclohexyl)carbonyl]aznino}furo[3,2-c]pyridine-2-carboxaxnide; disorders caused by thrombi and emboli in a mammal; decreased toxicity, and causes few side effects |
| 05/04/2006 | US20060094717 Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives |
| 05/04/2006 | US20060094057 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
| 05/04/2006 | US20060093666 Formulations for tyrosine kinase inhibitors |
| 05/03/2006 | EP1651598A2 Polyfluorinated compounds useful as surfactants, foam control agents and/or rheology modifiers |
| 05/03/2006 | EP1651232A2 Compounds for inflammation and immune-related uses |
| 05/03/2006 | EP1651231A2 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
| 05/03/2006 | EP1562902B1 2-pyridone derivatives as inhibitors of neutrophile elastase |
| 05/03/2006 | EP1515955A4 Chemical process |
| 05/03/2006 | EP1194404B1 Inhibitors of aspartyl protease |
| 05/03/2006 | CN1768050A Benzopyran compounds useful for treating inflammatory conditions |
| 05/03/2006 | CN1768036A Indolone-acetamide derivatives, processes for preparing them and their uses |
| 05/03/2006 | CN1765899A Diazabicyclic central nervous system active agents |
| 05/03/2006 | CN1765891A Novel aryloxy-alkyl-dialkylamines compound |
| 05/02/2006 | US7038070 Coordination polymerization catalysts |
| 05/02/2006 | US7038067 Process for synthesizing d-tocotrienols from 2-vinylchromane compound |
| 05/02/2006 | US7037917 Nitrogen compounds such as 4-((4-amino-5-bromo-6-(4-cyano-2,6-dimethylphenyloxy)-2 -pyrimidinyl)amino)benzonitrile, used as protease inhibitors for prophylaxis of viral diseases |
| 05/02/2006 | CA2334012C 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 04/27/2006 | US20060089345 Indole derivatives, method for preparating same and pharmaceutical compositions containing same |
| 04/27/2006 | DE10164687B4 Crystalline citalopram base and salts with high purity useful for treatment of depression |
| 04/26/2006 | EP1650212A2 Optically active quaternary ammonium salt, process for producing the same, and process for producing optically active alpha-amino acid derivative with the same |
| 04/26/2006 | EP1648995A2 Compositions for purifying and crystallizing molecules of interest |
| 04/26/2006 | EP1648870A2 Sulfonic acid derivatives of polycyclic dyes used for analytical applications |
| 04/26/2006 | EP1648457A2 Piperidine derivatives as melanocortin-4 receptor agonists |
| 04/26/2006 | CN1764454A Cyclic protein tyrosine kinase inhibitors |
| 04/26/2006 | CN1764381A Formulations for tyrosine kinase inhibitors |
| 04/26/2006 | CN1763060A Metallocene compound, indene compound and application thereof |
| 04/26/2006 | CN1763016A Preparation of aminopyrimidine compounds. |
| 04/26/2006 | CN1762957A 2,3-dihydro-1-indene compound and preparation method thereof |
| 04/25/2006 | US7034151 1,4-dihydro-4-oxo-pyrrolo[2,1-f][1,2,4]triazine-6-carboxylates; novel approach to the formation of the bicyclic heterocyclic ring system |
| 04/25/2006 | US7034021 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/25/2006 | CA2433035C Pharmaceutical compositions comprising amlodipine maleate |
| 04/20/2006 | WO2006041381A1 Polymorph of n,n-diethyl-4-(3-fluorophenyl-piperidin-4-ylidene-methyl)-benzamide hydrochloride salt |
| 04/20/2006 | US20060084811 Method for the synthesis of a benzimidazole compound |
| 04/19/2006 | EP1294724B1 Pyrrolo¬2,3-d|pyrimidine compounds as immunosuppressive agents |
| 04/19/2006 | CN1761670A Novel compounds |
| 04/19/2006 | CN1251680C Compositions comprising cytosine derivatives for the treatment of cancer |
| 04/18/2006 | US7030240 Piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 04/18/2006 | US7030141 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 04/18/2006 | US7030106 Ezetimibe formulation with lactose, croscarmellose sodium, povidone, sodium lauryl sulfate, magnesium stearate and microcrystalline cellulose |
| 04/18/2006 | CA2037098C Hexahydrobenz ¢cd! indoles and processes for preparation thereof |
| 04/13/2006 | WO2006038880A1 New composition and method |
| 04/13/2006 | WO2006038872A1 New process for the preparation of phosphinic acid |
| 04/13/2006 | WO2006038870A1 New process for the preparation of alkyl phosphinic acids |
| 04/12/2006 | EP1644362A2 Indolinone hydrazides as c-met inhibitors |
| 04/12/2006 | EP1643902A2 Multi-mode internal imaging |
| 04/12/2006 | EP1401828B1 N-formyl hydroxylamine compounds as inhibitors of pdf |
| 04/12/2006 | CN1759116A Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 04/12/2006 | CN1759111A Imidazol-4-yl-ethynyl-pyridine derivatives |
| 04/12/2006 | CN1757634A Intermidiate for preparing 1,2-oxygen nitrogen heterocyclic-2-alkene acylbenzene and its preparation |
| 04/12/2006 | CN1250223C Pyrrolo-triazine and pyrimidine compounds |
| 04/11/2006 | US7026331 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct |
| 04/11/2006 | US7026270 malayamycin A and desmethylmalayamycin A prepared from a previously unknown strain of Streptomyces malaysiensis, used for combating or controlling phytopathogenic fungi |
| 04/11/2006 | CA2199117C Compounds and methods for the treatment of cancer |
| 04/06/2006 | WO2005058814A3 Biocidal siloxane coating material containing n-halogenated amine and amide functional groups |
| 04/06/2006 | US20060074122 e.g., N-butyl-6-chloro-5-phenyl-1H-indazol-3-amine; kinase inhibitor; obesity and stroke; diseases involving phosphorylation of the tau protein such as Alzheimer's disease, Parkinson's disease, frontoparietal dementia |
| 04/06/2006 | US20060074112 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/05/2006 | EP1641793A1 Novel imidazopyridine compound ii with therapeutic effect |
| 04/05/2006 | EP1641781A2 Benzodiazepine cgrp receptor antagonists |
| 04/05/2006 | EP1641767A2 Bicyclic heterocycles, drugs containing said compounds, the use thereof and method for preparing the same |
| 04/05/2006 | EP1641535A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 04/05/2006 | EP1641481A2 Formation of novel erythropoietin conjugates using transglutaminase |
| 04/05/2006 | EP1641464A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 04/05/2006 | EP1330249B1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 04/05/2006 | EP1294720B1 Non-nucleoside reverse transcriptase inhibitors |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/04/2006 | US7022686 A1 adenosine receptro antagonists |
| 03/30/2006 | WO2006033620A1 New heterocyclic amides |
| 03/30/2006 | WO2005044793A3 Nitrogen-containing fused heterocyclic compounds |